Hosted on MSN

How glycoprotein GP38 from Crimean-Congo hemorrhagic fever virus could advance monoclonal antibody therapies

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases, in collaboration with scientists from the Albert ...
News Medical

GP38 identified as key viral toxin and vaccine target in Crimean-Congo hemorrhagic fever virus research

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert ...
EurekAlert!

Researchers’ study show advancements in GP38 contributions to CCHFV and monoclonal antibody therapies

Human pulmonary microvascular endothelial cells (HPMECs) were treated with GP38 and were stained for endothelial glycocalyx layer component sialic acid by immunofluorescence. Measurement of the ...
FierceBiotech

Antibodies stop tissue damage and reduce virus levels in mice with deadly Crimean-Congo hemorrhagic fever

Researchers studying a deadly virus discovered a key protein behind its lethality and successfully used antibodies to stop that protein from causing dangerous fluid leakage in mice. The results, ...